Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cat and mouse.

Greg M Cole1, Sally A Frautschy

  • 1Greater Los Angeles Healthcare System, Veterans Administration Medical Center, Geriatric Research Education Clinical Center, North Hills, California 91343, USA.

Neuron
|September 20, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In Vitro and In Vivo Evaluation of Small-Molecule Disassemblers of Pathological Tau Fibrils.

ACS chemical neuroscience·2026
Same author

Drug Development.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Basic Science and Pathogenesis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Basic Science and Pathogenesis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Harnessing cGAS-STING signaling to counteract the genotoxic-immune nexus in tauopathy.

bioRxiv : the preprint server for biology·2025
Same author

Disruption of electrophysiological rhythms and memory impairment in an Alzheimer's transgenic rat model.

Alzheimer's research & therapy·2025
Same journal

Fast-conducting mechanonociceptors uniquely engage reflexive and affective pain circuitry to drive protective responses.

Neuron·2026
Same journal

Sparse component analysis: A method that uncovers separable computations within neural population activity.

Neuron·2026
Same journal

Spatiomolecular mapping reveals anatomical organization of heterogeneous cell types in the human nucleus accumbens.

Neuron·2026
Same journal

TGF-β1-induced endothelial transcytosis drives blood-brain barrier leakage during aging.

Neuron·2026
Same journal

Image space opens up for visual neuroscience.

Neuron·2026
Same journal

Septal GLP-1 receptors control alcohol taking and seeking.

Neuron·2026
See all related articles

Cathepsin B plays a complex role in Alzheimer's disease. Increased expression degrades amyloid plaques, but inactivation accelerates beta-amyloidosis, suggesting a dual function in disease progression.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Alzheimer's disease (AD) is characterized by the accumulation of amyloid-beta (Abeta) peptides.
  • Cathepsin B, a lysosomal protease, is involved in amyloid-beta metabolism, but its precise role in AD pathogenesis is debated.
  • Previous studies have yielded conflicting results regarding cathepsin B's contribution to AD.

Discussion:

  • Mueller-Steiner et al. investigated the impact of cathepsin B expression levels in aged APP transgenic mice, a model for AD.
  • The study manipulated cathepsin B levels to elucidate its direct effects on amyloid pathology.
  • Findings provide new insights into the intricate mechanisms underlying amyloid plaque formation and degradation.

Key Insights:

  • Elevated cathepsin B expression demonstrated a capacity to degrade preformed oligomeric and fibrillar forms of amyloid-beta.

Related Experiment Videos

  • Conversely, inactivation of cathepsin B led to accelerated beta-amyloidosis, indicating a protective role at sufficient levels.
  • These results highlight a critical threshold effect of cathepsin B in modulating AD pathology.

    • Outlook:

    • The findings suggest that modulating cathepsin B activity could be a potential therapeutic strategy for Alzheimer's disease.
    • Further research is warranted to explore the therapeutic window and specificity of targeting cathepsin B in AD.
    • Understanding the precise molecular interactions of cathepsin B with amyloid-beta species is crucial for developing targeted interventions.